On the Call: Merck/Human Health EVP/Adam Schechter
16:17 EDT 27 Jul 2012 | PharmPro
Merck executives and analysts discussed several experimental medicines wrapping up late-stage testing, drugs for which Merck will soon apply for regulatory approval, during a conference call on second-quarter results. One of the most promising is an..
Original Article: On the Call: Merck/Human Health EVP/Adam Schechter
More From BioPortfolio on "On the Call: Merck/Human Health EVP/Adam Schechter"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
